Recovery Center Outcome Study

Published May 2, 2013

Recovery Center Outcome Study –

Zohydro – Is There Enough Upside For Zogenix?

Filed under: drug abuse treatment outcome study

The company is currently awaiting the outcome of a New Drug Application (NDA) from the Food and Drug Administration (FDA) for the drug Zohydro ERTM; the first orally active, extended release, single entity hydrocodone bitartate capsule for the …
Read more on Seeking Alpha

Media Advisory: Governor General to Invest 44 Recipients Into the Order of …

Filed under: drug abuse treatment outcome study

Director emeritus of biobehavioural research at the Centre for Addiction and Mental Health, and professor emeritus of pharmacology at the University of Toronto, he has been one of the pioneers of the modern scientific study of addictions. Spanning six …
Read more on Wall Street Journal (press release)

Data from Inovalon's MORE(2) Registry® Enables Comparative Risk and …

Filed under: drug abuse treatment outcome study

The objective was to evaluate the relative likelihood of severe cutaneous reactions (Steven-Johnson Syndrome, toxic epidermal necrolysis), aseptic meningitis, and organ dysfunction (pancreatitis, hepatotoxicity) associated with antiepileptic drugs …
Read more on Sacramento Bee

OncoGenex Announces Plans for the Initiation of the Rainier™ Clinical Trial …

Filed under: drug abuse treatment outcome study

"The Rainier trial provides us the opportunity to explore the role of Hsp27 in pancreatic cancer, and the potential ability of OGX-427 to improve on clinical outcomes when added to combination chemotherapy." … ABOUT OGX-427 and ORCA™ OGX-427 is a …
Read more on Sacramento Bee